Claudia Helena M C De Oliveira
About Claudia Helena M C De Oliveira
Claudia Helena M C De Oliveira is the Clinical Development Lead for Immunology & Fibrosis at Bristol Myers Squibb in Princeton, New Jersey. She has extensive experience in clinical development, particularly in the fields of Diabetes, Obesity, and Non-Alcoholic Steatohepatitis (NASH).
Company
Claudia Helena M C De Oliveira is currently employed at Bristol Myers Squibb. The company is known for its focus on healthcare and pharmaceutical innovation. Claudia operates out of their Princeton, New Jersey office, contributing her extensive experience in clinical development to her role in Immunology & Fibrosis.
Title
Claudia Helena M C De Oliveira holds the position of Clinical Development Lead, Immunology & Fibrosis at Bristol Myers Squibb. In this role, she oversees clinical strategies and development processes pertinent to immunological and fibrotic conditions.
Professional Experience
Claudia Helena M C De Oliveira has an extensive professional background in the medical and clinical research fields. Previously, she served as Senior Clinical Trial Lead for Liver Fibrosis at Bristol Myers Squibb from 2020 to 2022. Before that, she was the Senior Clinical Research Director for Diabetes Development at Sanofi for four years. At QuintilesIMS, she served in various significant roles including Senior Medical Director, Medical Director, and Associate Medical Director within the Cardiovascular & Metabolic Unit. Additionally, her career includes positions at the UNC Diabetes Care Center, Grupo Fleury, Eli Lilly, Santa Helena Hospital, and several other notable institutions in Brazil.
Education and Expertise
Claudia Helena M C De Oliveira holds an MPH in Health Behavior & Health Education from the University of North Carolina at Chapel Hill. She achieved her PhD in Medicine - Endocrinology from Universidade Federal de São Paulo, where she also earned an MSc in the same field. Additionally, she completed a post-doctoral fellowship studying Thyroid Hormone Receptor Signalling at the University of California, San Francisco. Her medical education began with earning an MD from Universidade Federal de Uberlândia. Claudia also completed an Endocrinology residency at Hospital do Servidor Público do Estado de Sao Paulo - IAMSPE.
Specializations
Claudia Helena M C De Oliveira specializes in clinical development for chronic conditions such as Diabetes, Obesity, and Non-Alcoholic Steatohepatitis (NASH). With a focus on endocrinology and metabolism, her work involves leading clinical strategies and participating in therapeutic advancements within these specialties.